Benzinga··Vandana SinghNovo Nordisk Scores Historic FDA Win With First Weekly Basal Insulin
Novo Nordisk wins FDA approval for Awiqli, the first once-weekly basal insulin for Type 2 diabetes, potentially improving patient adherence and capturing significant market share.
NVOFDA approvalclinical trial